Colombia vs Myanmar: Adults (ages 15+) and children (ages 0-14) newly infected with HIV
Colombia
12,000
in 2023
Myanmar
11,000
in 2024
Colombia rank
18th
Myanmar rank
20th
Adults (ages 15+) and children (ages 0-14) newly infected with HIV over time
- Colombia
- Myanmar
How they compare
Colombia currently reports 12,000 against 11,000 in Myanmar, a difference of 1,000.
That makes Colombia's figure about 1.1 times Myanmar's.
The two have swapped places 3 times across 34 shared years of data; in 1990 it was Myanmar ahead.
Colombia ranks 18th and Myanmar ranks 20th of 146 countries.
Across the 4 decades both report, Colombia averaged higher in 1 and Myanmar in 3.
Head to head by decade
| Decade | Colombia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 11,390 | 17,100 | 5,710 | Myanmar |
| 2000s | 11,800 | 22,900 | 11,100 | Myanmar |
| 2010s | 11,400 | 15,000 | 3,600 | Myanmar |
| 2020s | 12,250 | 11,500 | 750 | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (ages 0-14) newly infected with hiv, Colombia or Myanmar?
- Colombia, at 12,000 against 11,000 in Myanmar as of 2023.
- What is the difference in adults (ages 15+) and children (ages 0-14) newly infected with hiv between Colombia and Myanmar?
- 1,000, with Colombia ahead.
- How many years of comparable data are there for Colombia and Myanmar?
- 34 years are reported by both, from 1990 to 2023.
- How do Colombia and Myanmar rank globally for adults (ages 15+) and children (ages 0-14) newly infected with hiv?
- Colombia ranks 18th and Myanmar ranks 20th of 146 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Adults (ages 15+) and children (ages 0-14) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of adults (ages 15+) and children (ages 0-14) newly infected with HIV.